Efficacy and safety of the S 05985 [perindopril/amlodipine] combination compared with each individual component [perindopril, amlodipine]: Randomised, double-blind, placebo-controlled study over eight weeks in hypertensive patients.

Trial Profile

Efficacy and safety of the S 05985 [perindopril/amlodipine] combination compared with each individual component [perindopril, amlodipine]: Randomised, double-blind, placebo-controlled study over eight weeks in hypertensive patients.

Completed
Phase of Trial: Phase II

Latest Information Update: 13 Jun 2016

At a glance

  • Drugs Perindopril/amlodipine (Primary) ; Amlodipine; Perindopril
  • Indications Essential hypertension
  • Focus Therapeutic Use
  • Sponsors IRIS
  • Most Recent Events

    • 15 Jun 2015 Results of clinical trial program (4 studies) presented at the 25th European Meeting on Hypertension and Cardiovascular Protection.
    • 13 Aug 2011 Additional location added as reported by ISRCTN: Current Controlled Trials record.
    • 04 Mar 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top